Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
China
The Fisrt Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui Hunan Cancer Hospital, Changsha, Hunan